Randomized comparison between 2-link cell design biolimus A9-eluting stent and 3-link cell design everolimus-eluting stent in patients with de novo true coronary bifurcation lesions: the BEGIN trial-Reference-Cited by-同舟云学术

Randomized comparison between 2-link cell design biolimus A9-eluting stent and 3-link cell design everolimus-eluting stent in patients with de novo true coronary bifurcation lesions: the BEGIN trial

Published:2019-03-11 Issue:8 Volume:34 Page:1297-1308
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Yamawaki Masahiro,Muramatsu Toshiya,Ashida Kazuhiro,Kishi Koichi,Morino Yoshihiro,Kinoshita Yoshihisa,Fujii Takashi,Noguchi Yuichi,Hosogi Shingo,Kawai Kazuya,Hibi Kiyoshi,Shibata Yoshisato,Ohira Hiroshi,Morita Yasuhiro,Tarutani Yasuhiro,Toda Mikihito,Shimada Yoshihisa,Ikari Yuji,Ando Jiro,Hikichi Yutaka,Otsuka Yoritaka,Fuku Yasushi,Ito Shigenori,Katoh Harumi,Kadota Kazushige,Ito Yoshiaki,Mitsudo Kazuaki

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-019-01368-3.pdf

Reference24 articles.

1. Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky A, Meerkin D, Legrand V, Medina A, Lefevre T (2008) Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheter Cardiovasc Interv 71:175–183

2. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T (2014) Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5–7 years) follow-up of the coronary revascularization demonstrating outcome study-Kyoto registry cohort-2. Circ Cardiovasc Interv 7:168–179

3. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K, Takebayashi H, Yasuda T, Costa JR Jr, Tsuchiya Y, Jensen LO, Cristea E, Mehran R, Dangas GD, Iyer S, Collins M, Kreps EM, Colombo A, Stone GW, Leon MB, Moses JW (2005) Bifurcation coronary lesions treated with the “crush” technique: an intravascular ultrasound analysis. J Am Coll Cardiol 46:599–605

4. Burzotta F, Trani C, Todaro D, Mariani L, Talarico GP, Tommasino A, Giammarinaro M, Niccoli G, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F (2011) Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach. JACC Cardiovasc Interv 4:327–335

5. Lee JM, Hahn JY, Kang J, Park KW, Chun WJ, Rha SW, Yu CW, Jeong JO, Jeong MH, Yoon JH, Jang Y, Tahk SJ, Gwon HC, Koo BK, Kim HS (2015) Differential prognostic effect between first- and second-generation drug-eluting stents in coronary bifurcation lesions: patient-level analysis of the Korean bifurcation pooled cohorts. JACC Cardiovasc Interv 8:1318–1331

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Progress in Interventional Therapy for Coronary Bifurcation Lesions;Reviews in Cardiovascular Medicine;2024-01-04

2. Coronary Bifurcation Stenting: Review of Current Techniques and Evidence;Current Cardiology Reviews;2023-01

3. Optical coherence tomography-guided percutaneous coronary intervention: a review of current clinical applications;Cardiovascular Intervention and Therapeutics;2021-01-17